Category Archives: CooperVision Contact Lenses

Featured Stories

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

CooperVision Avaira Sphere Contact Lens Recall Most Serious Type, FDA Says

Federal regulators have deemed CooperVision Inc.’s expanded Avaira Sphere contact lens recall a Class I recall, according to an announcement from the U.S. Food & Drug Administration (FDA). The expanded recall, which was announced on November 15, involved CooperVision’s Avaira … Continue reading

Posted in CooperVision Contact Lenses, Defective Medical Devices |

CooperVision Adds 6 Million Avaira Sphere Lenses to Contact Lens Recall

CooperVision Inc. is expanding its recent contact lens recall to include to an additional brand. With the expansion, the < "http://www.yourlawyer.com/topics/overview/coopervision-avaira-topic-contact-lens-recall-eye-injury-lawyers">CooperVision contact lens recall now includes an additional 6 million lenses sold under the Avaira Sphere brand name. In October, … Continue reading

Posted in CooperVision Contact Lenses, Defective Medical Devices |

CooperVision Avaira Toric Contact Lens Recall Most Serious Type, FDA Says

CooperVision Inc.’s recent recall of Avaira Toric contact lenses has been deemed Class 1 by the U.S. Food & Drug Administration (FDA). Class 1 recalls are the FDA’s most serious type of recall, and means the agency has determined there … Continue reading

Posted in CooperVision Contact Lenses, Defective Medical Devices |

FDA Threat Prompts CooperVision to Reannounce Avaira Toric Contact Lens Recall

Pressure from U.S health regulators finally prompted CooperVision Inc. to step up its efforts to get the word out about its recent < "http://www.yourlawyer.com/topics/overview/coopervision-avaira-topic-contact-lens-recall-eye-injury-lawyers">recall of Avaira Toric contact lenses. According to a report from MSNBC, CooperVision is also acknowledging that … Continue reading

Posted in CooperVision Contact Lenses |

CooperVision Quietly Recalled Contact Lenses Amid Reports of Torn Corneas, Vision Problems

While contact lens wears were suffering from blurry vision and agonizing pain that, in some cases, led to emergency room hospital visits, CooperVision was recalling < "http://www.yourlawyer.com/topics/overview/coopervision-avaira-topic-contact-lens-recall-eye-injury-lawyers">Avaira Toric contact lenses in what one popular blogger described as a “stealth recall.” … Continue reading

Posted in CooperVision Contact Lenses |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.